Steering Committee

A steering committee composed of DIAN's principal investigators, associate directors, executive director, core leaders, performance site leaders, principal investigators from ADNI and the ADCS, a bioethicist, autosomal dominant Alzheimer's disease family representatives, representatives of the Food and Drug Administration, and appropriate staff from the National Institute of Aging will govern the research.

Resource Allocation Review Committee

A Resource Allocation Review Committee (RARC) will review requests for the use of biospecimens and recommend approval or disapproval to the Steering Committee.

David M. Holtzman (Chair), Washington University

Alison M. Goate, Washington University

Nigel J. Cairns, Washington University

Anne Fagan, Washington University

John K. Hsiao, National Institute on Aging

Gerard Schellenberg, University of Pennsylvania

John Q. Trojanowski, University of Pennsylvania

External Advisory Committee

Members of the External Advisory Committee (EAC) will review DIAN annually to evaluate progress, assess the effectiveness of communication among the grant components, and ensure that the conduct of the sites is of the highest possible quality. Current EAC members are: